BR112017006085A2 - compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila e uso como moduladores sgrm - Google Patents
compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila e uso como moduladores sgrmInfo
- Publication number
- BR112017006085A2 BR112017006085A2 BR112017006085A BR112017006085A BR112017006085A2 BR 112017006085 A2 BR112017006085 A2 BR 112017006085A2 BR 112017006085 A BR112017006085 A BR 112017006085A BR 112017006085 A BR112017006085 A BR 112017006085A BR 112017006085 A2 BR112017006085 A2 BR 112017006085A2
- Authority
- BR
- Brazil
- Prior art keywords
- dihydropyridin
- oxo
- alkyl
- compounds
- sgrm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
este relatório descritivo refere-se geralmente a compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila (incluindo seus sais). este relatório descritivo também se refere a composições farmacêuticas e kits compreendendo um tal composto, usos de um tal composto (incluindo métodos de tratamento e preparações medicamentosas), e processos para a preparação de um tal composto.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462055822P | 2014-09-26 | 2014-09-26 | |
| US62/055,822 | 2014-09-26 | ||
| PCT/EP2015/071862 WO2016046260A1 (en) | 2014-09-26 | 2015-09-23 | 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112017006085A2 true BR112017006085A2 (pt) | 2017-12-19 |
| BR112017006085B1 BR112017006085B1 (pt) | 2023-03-07 |
Family
ID=54252264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017006085-0A BR112017006085B1 (pt) | 2014-09-26 | 2015-09-23 | Composto ou um seu sal farmaceuticamente aceitável, composição farmacêutica, uso do composto ou seu sal farmaceuticamente aceitável |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US10196374B2 (pt) |
| EP (1) | EP3197878B1 (pt) |
| JP (1) | JP6430000B2 (pt) |
| KR (1) | KR101866706B1 (pt) |
| CN (1) | CN107001320B (pt) |
| AP (1) | AP2017009819A0 (pt) |
| AR (1) | AR105549A1 (pt) |
| AU (1) | AU2015323817B2 (pt) |
| BR (1) | BR112017006085B1 (pt) |
| CA (1) | CA2962312C (pt) |
| CL (1) | CL2017000715A1 (pt) |
| CO (1) | CO2017003955A2 (pt) |
| CR (1) | CR20170106A (pt) |
| DO (1) | DOP2017000064A (pt) |
| EA (1) | EA031945B1 (pt) |
| ES (1) | ES2751640T3 (pt) |
| GT (1) | GT201700058A (pt) |
| IL (1) | IL250886A0 (pt) |
| MX (1) | MX2017003697A (pt) |
| NI (1) | NI201700038A (pt) |
| NZ (1) | NZ730250A (pt) |
| PE (1) | PE20171110A1 (pt) |
| PH (1) | PH12017500533A1 (pt) |
| SG (1) | SG11201702225VA (pt) |
| SV (1) | SV2017005412A (pt) |
| TN (1) | TN2017000096A1 (pt) |
| TW (1) | TW201619146A (pt) |
| UY (1) | UY36327A (pt) |
| WO (1) | WO2016046260A1 (pt) |
| ZA (1) | ZA201702720B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017161518A1 (en) * | 2016-03-23 | 2017-09-28 | Astrazeneca Ab | New physical form |
| TW201927769A (zh) | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | 經取代之吡咯啶醯胺ｉｉ |
| JP2021506964A (ja) | 2017-12-18 | 2021-02-22 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 置換ピロリジンアミドｉ |
| KR20210114972A (ko) | 2019-01-11 | 2021-09-24 | 그뤼넨탈 게엠베하 | 치환된 피롤리딘 아마이드 iii |
| WO2020254552A2 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides v |
| EP3986885B1 (en) | 2019-06-19 | 2023-05-03 | Grünenthal GmbH | Substituted pyrrolidine amides iv |
| CN114929684B (zh) * | 2019-12-31 | 2023-08-18 | 南京明德新药研发有限公司 | 苯并吡唑类化合物 |
| WO2022008705A1 (en) | 2020-07-09 | 2022-01-13 | Grünenthal GmbH | Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor |
| CN115667237A (zh) * | 2020-07-17 | 2023-01-31 | 成都苑东生物制药股份有限公司 | 作为bet抑制剂的新型杂环化合物 |
| WO2023041695A1 (en) | 2021-09-20 | 2023-03-23 | Astrazeneca Ab | Methods of treating inflammatory diseases with a selective glucocorticoid receptor modulator |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008506669A (ja) * | 2004-07-16 | 2008-03-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 神経変性疾患の処置に適するピペリジン、ピペラジンもしくはモルホリンの二量体化合物またはそれらの７−員同族体 |
| JO2754B1 (en) * | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| TWI445705B (zh) * | 2008-05-20 | 2014-07-21 | Astrazeneca Ab | 經苯基及苯并二基取代之吲唑衍生物 |
-
2015
- 2015-09-23 SG SG11201702225VA patent/SG11201702225VA/en unknown
- 2015-09-23 AP AP2017009819A patent/AP2017009819A0/en unknown
- 2015-09-23 EA EA201790496A patent/EA031945B1/ru not_active IP Right Cessation
- 2015-09-23 CA CA2962312A patent/CA2962312C/en active Active
- 2015-09-23 PE PE2017000467A patent/PE20171110A1/es unknown
- 2015-09-23 US US15/513,655 patent/US10196374B2/en active Active
- 2015-09-23 WO PCT/EP2015/071862 patent/WO2016046260A1/en active Application Filing
- 2015-09-23 MX MX2017003697A patent/MX2017003697A/es active IP Right Grant
- 2015-09-23 EP EP15775130.6A patent/EP3197878B1/en active Active
- 2015-09-23 TN TN2017000096A patent/TN2017000096A1/en unknown
- 2015-09-23 JP JP2017515945A patent/JP6430000B2/ja active Active
- 2015-09-23 CN CN201580064182.1A patent/CN107001320B/zh active Active
- 2015-09-23 BR BR112017006085-0A patent/BR112017006085B1/pt active IP Right Grant
- 2015-09-23 AU AU2015323817A patent/AU2015323817B2/en active Active
- 2015-09-23 ES ES15775130T patent/ES2751640T3/es active Active
- 2015-09-23 KR KR1020177007804A patent/KR101866706B1/ko active IP Right Grant
- 2015-09-23 CR CR20170106A patent/CR20170106A/es unknown
- 2015-09-23 NZ NZ730250A patent/NZ730250A/en not_active IP Right Cessation
- 2015-09-25 TW TW104131819A patent/TW201619146A/zh unknown
- 2015-09-25 AR ARP150103099A patent/AR105549A1/es unknown
- 2015-09-25 UY UY0001036327A patent/UY36327A/es not_active Application Discontinuation
-
2017
- 2017-03-02 IL IL250886A patent/IL250886A0/en active IP Right Grant
- 2017-03-08 DO DO2017000064A patent/DOP2017000064A/es unknown
- 2017-03-22 GT GT201700058A patent/GT201700058A/es unknown
- 2017-03-23 PH PH12017500533A patent/PH12017500533A1/en unknown
- 2017-03-24 SV SV2017005412A patent/SV2017005412A/es unknown
- 2017-03-24 CL CL2017000715A patent/CL2017000715A1/es unknown
- 2017-03-24 NI NI201700038A patent/NI201700038A/es unknown
- 2017-04-18 ZA ZA2017/02720A patent/ZA201702720B/en unknown
- 2017-04-24 CO CONC2017/0003955A patent/CO2017003955A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017006085A2 (pt) | compostos 1-alquil-6-oxo-1,6-di-hidropiridin-3-ila e uso como moduladores sgrm | |
| CL2018003681A1 (es) | Derivados de ácido borónico y usos terapéuticos de los mismos | |
| BR112018005497A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| ECSP17007538A (es) | 2-(morfolin-4-il)-1,7-naftiridinas | |
| CR20160564A (es) | Dinucleótidos cíclicos como moduladores de sting | |
| BR112016026291A2 (pt) | Derivados do ácido borônico e usos terapêuticos dos mesmos | |
| UY39706A (es) | Derivados de (1hindol- 3-il)-2-(4-cloro-2-metoxi-fenil)-2-((3-metoxi-5-(metilsulfonil) fenil)amino)etanona como inhibidores de la replicación del virus del dengue | |
| UY36342A (es) | Nuevos derivados de aminoalquilbenzotiazepinas y usos de los mismos | |
| BR112017011972A2 (pt) | derivados de azabicicloctano como agonistas de fxr para uso no tratamento de doenças hepáticas e gastrintestinais | |
| BR112017013491A2 (pt) | compostos de pirimidina fundida para o tratamento de hiv | |
| CR20150454A (es) | Compuestos amida para el tratamiento de vih | |
| BR112017013440A2 (pt) | compostos de isoquinolina para o tratamento de hiv | |
| UY37645A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| UY37646A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| BR112016008468A2 (pt) | Composto de fórmula, composição farmacêutica, composto, uso de um composto e método para o tratamento ou melhora de câncer | |
| BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
| TW201613864A (en) | Novel compounds | |
| BR112017001334A2 (pt) | compostos de imidazopiridazina, seu uso e composição farmacêutica que os compreende | |
| BR112017009471A2 (pt) | síntese de copanlisib e seu sal de di-hidrocloreto. | |
| BR112017002852A2 (pt) | compostos de azetidiniloxifenilpirrolidina | |
| BR112017028456A2 (pt) | composto, e, método de prevenção e/ou tratamento de hiv | |
| BR112017004580A2 (pt) | composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento. | |
| CR20160529A (es) | Composiciones farmacéuticas para tratar enfermedades infecciosas | |
| DOP2018000049A (es) | Compuestos para uso en aplicaciones antibacterianas | |
| PE20170430A1 (es) | Arilhidrazidas que contienen una fraccion de 2-piridona como agentes antibacterianos selectivos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/09/2015, OBSERVADAS AS CONDICOES LEGAIS |